Robert Wieder

Department of Medicine and New Jersey Medical School Cancer Center, Rutgers New Jersey Medical School

Affiliated withRutgers New Jersey Medical School

Research Area

Biography

Robert Wieder has not added Biography.
If you are Robert Wieder and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 9	2015

Other Publications

Article	Year
Phase I/II trial of accutane as a potentiator of carboplatin and paclitaxel in squamous cell carcinomas. American journal of clinical oncology\| PubMed ID: 12393981	2002
Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignancies. Investigational new drugs\| PubMed ID: 14586212	2003
All-trans retinoic acid potentiates Taxotere-induced cell death mediated by Jun N-terminal kinase in breast cancer cells. Oncogene\| PubMed ID: 14724571	2004
Integrin alpha5beta1 promotes survival of growth-arrested breast cancer cells: an in vitro paradigm for breast cancer dormancy in bone marrow. Cancer research\| PubMed ID: 15231661	2004
Expression of FGF-2 alters focal adhesion dynamics in migration-restricted MDA-MB-231 breast cancer cells. Breast cancer research and treatment\| PubMed ID: 15538042	2004
Insurgent micrometastases: sleeper cells and harboring the enemy. Journal of surgical oncology\| PubMed ID: 15726617	2005
Flavopiridol blocks integrin-mediated survival in dormant breast cancer cells. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 15756030	2005
TUNEL assay as a measure of chemotherapy-induced apoptosis. Methods in molecular medicine\| PubMed ID: 15911970	2005
Microfluidic techniques for single-cell protein expression analysis. Clinical chemistry\| PubMed ID: 16556686	2006
Coordinate loss of fibroblast growth factor 2 and laminin 5 expression during neoplastic progression of mammary duct epithelium. Human pathology\| PubMed ID: 16996573	2007
Influence of prescription benefits on reported pain in cancer patients. Pain medicine (Malden, Mass.)\| PubMed ID: 18346057	2008
CCAAT enhancer-binding protein alpha is a molecular target of 1,25-dihydroxyvitamin D3 in MCF-7 breast cancer cells. The Journal of biological chemistry\| PubMed ID: 19054766	2009
Dual FGF-2 and intergrin alpha5beta1 signaling mediate GRAF-induced RhoA inactivation in a model of breast cancer dormancy. Cancer microenvironment : official journal of the International Cancer Microenvironment Society\| PubMed ID: 19308677	2009
A pilot phase II trial of all-trans retinoic acid (Vesanoid) and paclitaxel (Taxol) in patients with recurrent or metastatic breast cancer. Investigational new drugs\| PubMed ID: 20596747	2011
Determination of single cell surface protein expression using a tagless microfluidic method. Lab on a chip\| PubMed ID: 22415775	2012
Collagen I provides a survival advantage to MD-1483 head and neck squamous cell carcinoma cells through phosphoinositol 3-kinase signaling. Anticancer research\| PubMed ID: 23393327	2013
Establishing a minority-based community clinical oncology program: the University of Medicine and Dentistry of New Jersey, New Jersey Medical School-university Hospital Cancer Center experie... Journal of oncology practice / American Society of Clinical Oncology\| PubMed ID: 23814524	2013
Prescription coverage in indigent patients affects the use of long-acting opioids in the management of cancer pain. Pain medicine (Malden, Mass.)\| PubMed ID: 24106748	2014